Pages that link to "Q68718298"

The following pages link to Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats (Q68718298):

Displaying 44 items.

• The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice (Q26830744) (← links)
• The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton (Q28539057) (← links)
• Cancer treatment-related bone disease (Q30438185) (← links)
• Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys (Q30692945) (← links)
• Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study (Q33300855) (← links)
• Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone (Q33529369) (← links)
• The effects of SERMs on the skeleton (Q33757731) (← links)
• The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens (Q33856027) (← links)
• The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer (Q34311300) (← links)
• From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). (Q34315413) (← links)
• Animal models for osteoporosis (Q34435610) (← links)
• Elucidation of the molecular mechanism of action of selective estrogen receptor modulators (Q34525080) (← links)
• The ovariectomized rat model of postmenopausal bone loss (Q34669140) (← links)
• Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancer (Q35066907) (← links)
• Cellular effects of early exposure to sex hormones and antihormones (Q35507346) (← links)
• Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors (Q35593300) (← links)
• Selective estrogen receptor modulation: concept and consequences in cancer (Q35721863) (← links)
• Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro (Q36052802) (← links)
• Mice lacking AMP-activated protein kinase α1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment. (Q36189054) (← links)
• Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer (Q36684234) (← links)
• Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen (Q36761985) (← links)
• SERMs for the treatment and prevention of breast cancer (Q36794420) (← links)
• The effects of tamoxifen treatment on the endometrium. (Q36800204) (← links)
• Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss (Q37353908) (← links)
• Long-term adjuvant tamoxifen therapy for breast cancer (Q37942117) (← links)
• The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole (Q39524591) (← links)
• Mechanisms of hormone resistance in breast cancer (Q40770822) (← links)
• Molecular mechanisms and future uses of antiestrogens (Q40892619) (← links)
• Gonadal hormone substitutes (Q41517359) (← links)
• Gynaecological aspects of tamoxifen treatment in breast cancer patients (Q41702048) (← links)
• The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat: a histomorphometric study (Q43754087) (← links)
• Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice. (Q47134253) (← links)
• Skeletal and Uterotrophic Effects of Endoxifen in Female Rats (Q47620125) (← links)
• Evidence That Ibuprofen Antagonizes Selective Actions of Estrogen and Tamoxifen on Rat Bone (Q48017579) (← links)
• Differences of bone mass and bone structure in osteopenic rat models caused by spinal cord injury and ovariectomy (Q51770844) (← links)
• The anabolic effect of estrogen on endosteal bone formation in the mouse is attenuated by ovariohysterectomy: a role for the uterus in the skeletal response to estrogen? (Q67573301) (← links)
• Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat (Q67879360) (← links)
• The effect of conjugated equine estrogens on ovariectomy-induced osteopenia in the rat (Q68495351) (← links)
• Ovarian status influences the skeletal effects of tamoxifen in adult rats (Q71810652) (← links)
• Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model (Q71956280) (← links)
• Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats (Q73743974) (← links)
• Selective oestrogen receptor modulation: HRT replacement therapy? (Q73794321) (← links)
• Effect of medication on biomechanical properties of rabbit bones: Heparin induced osteoporosis (Q74142970) (← links)
• Ibandronate Treatment Before and After Implant Insertion Impairs Osseointegration in Aged Rats with Ovariectomy Induced Osteoporosis (Q92358433) (← links)